| Description | TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor, is a valuable compound for autoimmune disease research[1]. |
| In vitro | TLR7/8-IN-1 represents a crystalline form of an inhibitor targeting TLR7 and TLR8 receptors. This compound holds potential for studying autoimmune diseases in a research setting.[1] |
| Synonyms | TLR7/8-IN-1 |
| molecular weight | 532.68 |
| Molecular formula | C29H40N8O2 |
| CAS | 2205095-75-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 11.2 mg/mL (21.1 mM ), Sonication is recommended. |
| References | 1. CRYSTALLINE FORMS OF ATLR7/TLRSINHIBITOR. WO2019220390. |